Predicting the response to Ondansetron, a 5HT3 receptor antagonist, in irritable bowel syndrome with diarrhoea: the utility of clinical features and objective biomarkers
Background: Patients with diarrhoea predominant irritable bowel syndrome (IBS-D) suffer from loose frequent stools with associated urgency and fear of incontinence. Relief from these symptoms is an important unmet need. The 5-HT3 receptor antagonist Alosetron has been shown to increase stool consis...
| Main Author: | Garsed, Klara C. |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/14332/ |
Similar Items
Biomarkers to assess an anti-inflammatory treatment for irritable bowel syndrome: mast cell assays and magnetic resonance imaging
by: Lam, Ching Yin
Published: (2015)
by: Lam, Ching Yin
Published: (2015)
A mechanistic multi-centre, parallel group, randomised placebo controlled trial of Mesalazine for treatment of irritable bowel syndrome with diarrhoea (IBS-D)
by: Lam, Ching, et al.
Published: (2015)
by: Lam, Ching, et al.
Published: (2015)
The cognitive behavioural treatment of irritable bowel syndrome: feasibility of a nurse delivered model of guided self-help
by: Dainty, Andrew David
Published: (2016)
by: Dainty, Andrew David
Published: (2016)
Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome?: report of a case-control study in the General Practice Research Database
by: Card, Timothy R., et al.
Published: (2014)
by: Card, Timothy R., et al.
Published: (2014)
A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
by: Garsed, Klara, et al.
Published: (2013)
by: Garsed, Klara, et al.
Published: (2013)
Development, content validity and cross-cultural adaptation of a Patient-Reported Outcome Measure for Real-time Symptom Assessment in Irritable Bowel Syndrome
by: Vork, L., et al.
Published: (2017)
by: Vork, L., et al.
Published: (2017)
Post infectious IBS: defining its clinical features and prognosis using an internet-based survey
by: Card, Timothy, et al.
Published: (2018)
by: Card, Timothy, et al.
Published: (2018)
Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial
by: Yan, R., et al.
Published: (2020)
by: Yan, R., et al.
Published: (2020)
Corticotrophin releasing factor increases ascending colon volume after a fructose test meal in healthy humans: a randomised control trial
by: Murray, Kathryn, et al.
Published: (2016)
by: Murray, Kathryn, et al.
Published: (2016)
Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
by: Tooth, David, et al.
Published: (2014)
by: Tooth, David, et al.
Published: (2014)
Evolving new drug treatments for faecal incontinence
by: Maitra, Rudra Krishna
Published: (2017)
by: Maitra, Rudra Krishna
Published: (2017)
Investigation of the spiral secretion pattern of the serine protease autotransporter, EspC using innovative fluorescent labelling approaches
by: Ashawesh, Mahmoud
Published: (2016)
by: Ashawesh, Mahmoud
Published: (2016)
Assessment of the protein interaction between coagulation factor XII and corn trypsin inhibitor by molecular docking and biochemical validation
by: Hamad, Badraldin K., et al.
Published: (2017)
by: Hamad, Badraldin K., et al.
Published: (2017)
Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration
by: Khan, Gulafshana Hafeez, et al.
Published: (2014)
by: Khan, Gulafshana Hafeez, et al.
Published: (2014)
A Structural Study on the Specificity of F1 Protease
by: Muhamad, Azira
Published: (2005)
by: Muhamad, Azira
Published: (2005)
Activation of the inflammasome in bovine mammary macrophages by Streptococcus uberis
by: Tomes, Abbie
Published: (2024)
by: Tomes, Abbie
Published: (2024)
Phytobezoars in the Stomach and Small Bowel: CT Findings
by: Sun, Zhonghua, et al.
Published: (2014)
by: Sun, Zhonghua, et al.
Published: (2014)
Multifunctional serine protease inhibitor-coated water-soluble gold nanoparticles as a novel targeted approach for the treatment of inflammatory skin diseases
by: Limón, David, et al.
Published: (2018)
by: Limón, David, et al.
Published: (2018)
Effectiveness of educational interventions to raise men's awareness of bladder and bowel health
by: Tuckett, A., et al.
Published: (2011)
by: Tuckett, A., et al.
Published: (2011)
The epidemiology of irritable bowel syndrome
by: Canavan, Caroline, et al.
Published: (2014)
by: Canavan, Caroline, et al.
Published: (2014)
Irritable bowel syndrome, inflammatory bowel disease and the microbiome
by: Major, Giles, et al.
Published: (2014)
by: Major, Giles, et al.
Published: (2014)
Inflammatory bowel disease: clinical aspects and treatments
by: Fakhoury, M., et al.
Published: (2014)
by: Fakhoury, M., et al.
Published: (2014)
Mechanisms of transforming growth factor-β activation in airway smooth muscle cells and its role in asthma
by: Tatler, Amanda Louise
Published: (2010)
by: Tatler, Amanda Louise
Published: (2010)
THE IDENTIFICATION OF BIOMARKERS TO PREDICT RESPONSE TO TREATMENTS IN ASTHMA
by: Lissa, Sutherland
Published: (2019)
by: Lissa, Sutherland
Published: (2019)
Novel oral targeted therapies in inflammatory bowel disease
by: White, Jonathan Richard, et al.
Published: (2018)
by: White, Jonathan Richard, et al.
Published: (2018)
Adverse pregnancy outcomes among women with inflammatory bowel disease: a population based study from England
by: Abdul Sultan, Alyshah, et al.
Published: (2016)
by: Abdul Sultan, Alyshah, et al.
Published: (2016)
Intestinal failure in adults: recommendations from the ESPEN Expert Groups
by: Pironi, Loris, et al.
Published: (2018)
by: Pironi, Loris, et al.
Published: (2018)
Proteomic and transcriptomic analyses of protein biomarkers during early hyperinfection in strongyloidiasis
by: Al-Zihiry, Khalid Jameel Kadhim
Published: (2016)
by: Al-Zihiry, Khalid Jameel Kadhim
Published: (2016)
Extra-gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported
by: Card, Timothy R., et al.
Published: (2016)
by: Card, Timothy R., et al.
Published: (2016)
Lipidomic analysis of plasma samples from women with polycystic ovary syndrome
by: Haoula, Zeina, et al.
Published: (2015)
by: Haoula, Zeina, et al.
Published: (2015)
Ultrasound assessment of small bowel Crohn's disease: A mixed methods exploration of barriers and facilitators to implementation in adult NHS IBD services
by: Radford, Shellie
Published: (2023)
by: Radford, Shellie
Published: (2023)
The pattern of underlying cause of death in patients with inflammatory bowel disease in England: a record linkage study
by: Chu, Thomas P.C., et al.
Published: (2016)
by: Chu, Thomas P.C., et al.
Published: (2016)
A study on biomarkers in workers exposure to benzene
by: Cao, J., et al.
Published: (2002)
by: Cao, J., et al.
Published: (2002)
Risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity
by: Chu, Thomas P.C., et al.
Published: (2018)
by: Chu, Thomas P.C., et al.
Published: (2018)
Exploration of the impact of inflammatory bowel disease fatigue on the health-related quality of life of adults
by: Radford, Shellie Jean
Published: (2020)
by: Radford, Shellie Jean
Published: (2020)
Review article: the economic impact of the irritable bowel syndrome
by: Canavan, Caroline, et al.
Published: (2014)
by: Canavan, Caroline, et al.
Published: (2014)
Men's Help-seeking Behavior with Regards to Lower Bowel Symptoms
by: Oberoi, Devesh Varun, et al.
Published: (2015)
by: Oberoi, Devesh Varun, et al.
Published: (2015)
A potential biomarker for the Permian-Triassic ecological crisis
by: Grice, Kliti, et al.
Published: (2005)
by: Grice, Kliti, et al.
Published: (2005)
Biomarkers to predict advanced liver diseases
by: Alenezi, Yusef
Published: (2024)
by: Alenezi, Yusef
Published: (2024)
Non-invasive colonic imaging studies in inflammatory bowel disease
by: Alshammari, Meshari Turki
Published: (2024)
by: Alshammari, Meshari Turki
Published: (2024)
Similar Items
-
Biomarkers to assess an anti-inflammatory treatment for irritable bowel syndrome: mast cell assays and magnetic resonance imaging
by: Lam, Ching Yin
Published: (2015) -
A mechanistic multi-centre, parallel group, randomised placebo controlled trial of Mesalazine for treatment of irritable bowel syndrome with diarrhoea (IBS-D)
by: Lam, Ching, et al.
Published: (2015) -
The cognitive behavioural treatment of irritable bowel syndrome: feasibility of a nurse delivered model of guided self-help
by: Dainty, Andrew David
Published: (2016) -
Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome?: report of a case-control study in the General Practice Research Database
by: Card, Timothy R., et al.
Published: (2014) -
A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
by: Garsed, Klara, et al.
Published: (2013)